Filter
165
Text search:
Pre-exposure
Prophylaxis
Featured
Recommendations
10
New Publications
29
Language
Document type
No document type
85
Guidelines
41
Studies & Reports
25
Strategic & Response Plan
7
Manuals
3
Situation Updates
1
Resource Platforms
1
Infographics
1
Fact sheets
1
Countries / Regions
South Africa
5
Malawi
4
Eastern Europe
4
Sierra Leone
3
Ghana
3
Ukraine
3
Asia
3
Russia
3
Nigeria
2
Uganda
2
Zambia
2
Kenya
2
East and Southern Africa
2
South–East Asia Region
2
Latin America and the Carribbean
2
Georgia
2
Global
2
Cameroon
1
Philippines
1
India
1
Tanzania
1
Rwanda
1
Namibia
1
Brazil
1
Lesotho
1
Middle East and North Africa
1
Western and Central Europe
1
Paraguay
1
Africa
1
Authors & Publishers
Publication Years
Category
Countries
32
Clinical Guidelines
11
Women & Child Health
4
Public Health
3
Key Resources
2
Toolboxes
HIV
109
COVID-19
7
TB
5
NTDs
4
Planetary Health
2
Ebola & Marburg
1
Polio
1
Conflict
1
Rapid Response
1
Pharmacy
1
ECDC MISSION REPORT 19–21 September 2016 ; 14–15 November 2016
This tool offers practical advice on implementing HIV and STI programmes for and with sex workers. It is based on the recommendations in the guidance document on Prevention and treatment of HIV and other sexually transmitted infections for sex workers in low- and middle-income countries published in
...
Рекомендации ВОЗ по оказанию дородовой помощи для формирования положительного опыта беременности
23 February 2022
A summary of the commitments and targets within the United Nations General Assembly’s 2021 Political Declaration on HIV and AIDS.The United Nations General Assembly’s 2021 Political Declaration on AIDS features bold global commitments and targets for 2025 that are ambitious but
...
UNAIDS 2016 / Meeting Report
Rabies is fatal, vaccine-preventable disease responsible for an estimated 59,000 human deaths each year. Most cases are transmitted by dogs, and most deaths occur in underserved populations in Africa and Asia. Approximately 40% of deaths occur in children.
HIV drug resistance strategies focus on prevention through adherence and treatment optimization, surveillance to monitor resistance trends, and innovation in new drugs and diagnostics. Key approaches include implementing national action plans, strengthening laboratory capacity for monitoring, and pr
...